Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Aura Biosciences (AURA) Exchange Rate Effect (2025 - 2026)

Aura Biosciences filings provide 2 years of Exchange Rate Effect readings, the most recent being -$27000.0 for Q1 2026.

Quarterly Exchange Rate Effect fell 28.57% to -$27000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$192000.0 through Mar 2026, down 814.29% year-over-year, with the annual reading at -$186000.0 for FY2025, N/A changed from the prior year.
Exchange Rate Effect hit -$27000.0 in Q1 2026 for Aura Biosciences, up from -$160000.0 in the prior quarter.
Across five years, Exchange Rate Effect topped out at $9000.0 in Q2 2025 and bottomed at -$160000.0 in Q4 2025.